Healthcare IT Today September 5, 2025
Danny Lieberman

We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Ronen Veksler, Co-Founder and CEO at Promise Bio. Promise Bio is an early-stage tech-bio company coming out of AION Labs in Israel with strategic investors – AstraZeneca and Pfizer. They’ve built a cloud-based AI platform that uses advanced mass spectrometry-based proteomics and provides value for pharmaceutical companies in 4 ways: identifies new drug targets, predicts treatment response, analyzes the mechanism of action, and supports pathway engagement analysis.

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

  • Tell me about your journey to Promise Bio?
  • Who are your customers?
  • How do...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Conferences / Podcast, Pharma / Biotech, Precision Medicine, Trends
JPM 2026: Genoa Ventures’ Jenny Rooke on Next-Gen Clinical Assessment Tools
From Early Detection to Targeted Therapy: How AI is Reframing Precision Medicine
How Precision Medicine and AI are Evolving: An MD Anderson Perspective
Bringing Precision Medicine Into the Home
Inside the Virtual Cell: New Depths for Precision Medicine

Share Article